Skip to Content

WPI 3154 (Modafinil 100 mg)

Pill with imprint WPI 3154 is White, Capsule-shape and has been identified as Modafinil 100 mg. It is supplied by Watson Laboratories, Inc..

Modafinil is used in the treatment of shift work sleep disorder; narcolepsy; obstructive sleep apnea/hypopnea syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 100 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3154

Modafinil 100 mg WPI 3154
Modafinil 100 mg WPI 3154
Modafinil 100 mg WPI 3154 Front
Modafinil 100 mg WPI 3154 Back


WPI 3154
100 mg
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3499 Watson Pharmaceuticals, Inc.
42291-0599 AvKare, Inc.
00904-6423 Major Pharmaceuticals

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.